NIMESID Tablet by Dr Precision is a fast-acting, selective COX-2 inhibitor nonsteroidal anti-inflammatory drug (NSAID) containing Nimesulide, specifically formulated to provide rapid relief from mild to moderate pain, inflammation, and fever. It is ideal for managing conditions such as musculoskeletal disorders, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-operative pain, dysmenorrhea, and other acute inflammatory states. Manufactured under strict WHO-GMP compliant standards by Bluepill Express, NIMESID Tablet ensures high-quality, consistent efficacy and safety for short-term therapeutic use. The film-coated tablets improve swallowability while minimizing gastric discomfort, making them suitable for adult patients under medical supervision. The formulation targets prostaglandin synthesis selectively, offering pain and inflammation control with a reduced risk of gastrointestinal side effects common in traditional NSAIDs. Available in tamper-proof blister packs and export-ready bulk packaging, NIMESID is supported by comprehensive quality documentation including COA, product dossiers, and MSDS, with private labeling options for business partners. It is recommended for short duration therapy, with precautions advised in hepatic impairment and contraindications in children under 12, pregnant or lactating women, and those with known liver conditions.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Nimesulide, a selective COX-2 inhibitor |
| Therapeutic Uses | Relief from pain, inflammation, and fever due to musculoskeletal disorders, arthritis, dental pain, dysmenorrhea, post-operative pain |
| Onset of Action | Typically within 30 minutes |
| Formulation | Film-coated tablet for improved swallowability and reduced gastric irritation |
| Manufacturing Standards | Produced under WHO-GMP compliant facilities by Bluepill Express |
| Packaging | Tamper-proof blister packs for retail and export-optimized bulk packaging |
| Safety Profile | Selective COX-2 inhibition reduces gastrointestinal side effects compared to traditional NSAIDs |
| Quality Assurance | Rigorous dissolution, microbial, and stability testing; supported by COA, MSDS, and product dossier |
| Usage Recommendation | Short-term use under medical supervision; not recommended for children under 12, pregnant or lactating women, or those with liver impairment |
| Private Labeling | Available for global business partners |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Strength | Typically 100 mg Nimesulide per tablet (specific strength can be provided upon request) |
| Color and Shape | Film-coated, round/oval (refer to packaging) |
| Shelf Life | Typically 24 months under recommended storage conditions |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Expiry | As per packaging batch |
| Therapeutic Category | NSAID - selective COX-2 inhibitor |
| Manufacturing Location | Bluepill Express’s WHO-GMP certified plant |
| Packaging Details | Blister packs (strip sizes available on demand); bulk packaging for institutional orders |
| Regulatory Compliance | Compliant with international pharmaceutical manufacturing and export standards |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
NIMESID Tablet undergoes rigorous quality control measures including dissolution profile analysis, microbial contamination tests, and stability testing across multiple climatic zones to maintain consistent safety and efficacy in compliance with WHO-GMP standards.
NIMESID’s selective COX-2 inhibition targets the inflammatory pathways while sparing COX-1, significantly reducing the risk of gastrointestinal side effects often associated with traditional non-selective NSAIDs.
No, NIMESID Tablet is recommended only for short-term use under medical supervision due to potential hepatotoxicity risks linked with prolonged Nimesulide use.
Yes, Bluepill Express offers private labeling and customized packaging solutions for NIMESID Tablet to meet the branding needs of global B2B partners.
NIMESID is contraindicated in individuals with known hepatic impairment or history of liver disease and requires cautious use only under strict medical supervision to avoid hepatotoxicity.
NIMESID Tablet is supplied in tamper-proof blister packs optimized for retail and export-ready bulk packaging formats suitable for institutional buyers or pharmaceutical distributors.
Country Of Origin: India
NIMESID Tablet is a fast-acting nonsteroidal anti-inflammatory drug (NSAID) containing Nimesulide, used to relieve mild to moderate pain, reduce inflammation, and control fever in conditions like musculoskeletal disorders, dysmenorrhea, dental pain, and arthritis.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
NIMESID Tablet is an effective analgesic and anti-inflammatory medication developed to manage pain, inflammation, and fever across a wide range of medical conditions. Each tablet contains Nimesulide, a selective COX-2 inhibitor that helps block the production of prostaglandins responsible for inflammation and pain response. NIMESID offers quick relief with a favorable safety profile when used appropriately and for short durations.
The formulation is particularly effective in managing acute inflammatory conditions such as joint pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, dental pain, post-operative pain, and menstrual cramps. Its pharmacodynamic action provides both symptomatic and therapeutic benefits, reducing inflammation at the site of pain while also lowering body temperature when fever is present.
Manufactured by Bluepill Express, NIMESID Tablet is produced in state-of-the-art WHO-GMP-compliant facilities, ensuring consistent quality and adherence to international regulatory requirements. From sourcing of raw materials to final packaging, each step in the manufacturing process is closely monitored to ensure that the finished product meets global standards.
NIMESID Tablet acts quickly—often within 30 minutes—providing rapid pain relief and increased comfort for patients. Its action is more targeted compared to traditional NSAIDs, reducing the risk of gastrointestinal side effects associated with non-selective COX inhibition. However, like all NSAIDs, it should be taken with caution in individuals with a history of gastric ulcers, liver impairment, or NSAID hypersensitivity.
Bluepill Express offers NIMESID in tamper-proof blister packaging for retail distribution and in export-optimized formats for bulk or institutional sales. The tablet is film-coated to improve swallowability and reduce gastric discomfort. All batches undergo strict quality testing including dissolution profile analysis, microbial testing, and stability testing across various climatic zones.
As a trusted third-party manufacturer and exporter, Bluepill Express provides all supporting technical documents including Certificate of Analysis (COA), Product Dossiers, MSDS, and marketing authorization support upon request. Private labeling options are also available to meet branding needs of global partners.
NIMESID Tablet is recommended for adult patients and should be prescribed for short-term use under medical supervision. Long-term or unsupervised usage is discouraged due to potential hepatotoxicity, a known risk associated with prolonged use of Nimesulide. The product is not recommended for children under 12 years, pregnant or lactating women, or individuals with known hepatic conditions.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
